calendar
8,054 catalysts · 5,159 phase readout · 2,327 8k filing · 316 pdufa · 275 earnings · 108 phase 2 completion · 50 phase 1 completion
next 91 dayslessmore
MonWedFri
8,054 catalysts · 5,159 phase readout · 2,327 8k filing · 316 pdufa · 275 earnings · 108 phase 2 completion · 50 phase 1 completion
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01
Items: 8.01
Items: 7.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 7.01, 9.01
Items: 1.01, 7.01, 9.01
Items: 1.01, 3.02, 9.01
Items: 8.01
Items: 2.02, 9.01
Items: 1.01, 3.02, 5.02, 9.01
Items: 8.01, 9.01
Items: 5.07, 8.01
Items: 7.01, 9.01
Items: 1.01, 2.01, 2.02, 3.02, 3.03, 5.01, 5.02, 5.03, 5.05, 7.01, 9.01
Items: 5.02, 5.07, 9.01
Items: 3.02, 8.01, 9.01
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.
Items: 1.02, 7.01, 9.01
Items: 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 8.01, 9.01
Items: 1.01, 3.03, 5.01, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 1.01, 1.02, 2.01, 3.02, 5.02, 5.03, 7.01, 9.01
Items: 1.01, 3.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 9.01
Items: 2.02, 9.01
Items: 7.01, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
action date of January 4, 2027
action date of Jan. 21, 2027
Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: University of Alberta. Phase: . Conditions: Low Back Pain
Sponsor: Beijing Sport University. Phase: NA. Conditions: Patellofemoral Pain
Sponsor: Definium Therapeutics US, Inc.. Phase: PHASE3. Conditions: Major Depressive Disorder
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Unresectable Melanoma
Sponsor: The University of Queensland. Phase: NA. Conditions: Blood Culture Contamination, Infection